Executive Change: Incyte (NASDAQ:INCY) Appoints Pablo J. Cagnoni M.D. as President and Global Head of Research and Development
Wilmington, DE – Incyte has announced the appointment of Pablo Cagnoni as President and Global Head of Research and Development. About Incyte: Incyte is a global biopharmaceutical company founded in 2002 in Wilmington, Delaware, that…